MISTI NEWSON: Open Payments
NPI 1295400422 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,945 in 184 payments from 13 companies in 2025. Trend: 2023 $1,797 · 2024 $6,837 · 2025 $45,945
Honoraria: $15,357Speaker / faculty: $14,930Travel & lodging: $10,204Food & beverage: $5,079Education: $189Consulting: $186
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 70 | $24,265 |
| Axsome Therapeutics, Inc. | 33 | $19,089 |
| Teva Pharmaceuticals USA, Inc. | 11 | $562 |
| Neurocrine BioSciences, Inc. | 21 | $548 |
| Otsuka America Pharmaceutical, Inc. | 12 | $439 |
| Vanda Pharmaceuticals Inc. | 10 | $336 |
| Alkermes, Inc. | 13 | $263 |
| ABBVIE INC. | 6 | $162 |
| Janssen Pharmaceuticals, Inc | 4 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $69 |
Products named: COBENFY, Auvelity, INGREZZA, FANAPT, ABILIFY MAINTENA, REXULTI, UZEDY, AUSTEDO XR.
Industry payments across ID — which companies pay providers there.
